KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Deferred Taxes (2016 - 2026)

Medtronic (MDT) has disclosed Deferred Taxes for 13 consecutive years, with -$101.0 million as the latest value for Q1 2026.

  • Quarterly Deferred Taxes rose 26.81% to -$101.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$176.0 million through Jan 2026, up 48.08% year-over-year, with the annual reading at -$316.0 million for FY2025, 37.8% up from the prior year.
  • Deferred Taxes hit -$101.0 million in Q1 2026 for Medtronic, down from -$7.0 million in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $167.0 million in Q3 2025 to a low of -$370.0 million in Q2 2022.
  • Historically, Deferred Taxes has averaged -$94.8 million across 5 years, with a median of -$87.5 million in 2022.
  • Biggest five-year swings in Deferred Taxes: surged 108.97% in 2023 and later tumbled 1628.57% in 2024.
  • Year by year, Deferred Taxes stood at -$74.0 million in 2022, then surged by 51.35% to -$36.0 million in 2023, then grew by 13.89% to -$31.0 million in 2024, then surged by 77.42% to -$7.0 million in 2025, then crashed by 1342.86% to -$101.0 million in 2026.
  • Business Quant data shows Deferred Taxes for MDT at -$101.0 million in Q1 2026, -$7.0 million in Q4 2025, and $167.0 million in Q3 2025.